Absci Corp

General ticker "ABSI" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $366.3M

Absci Corp does not follow the US Stock Market performance with the rate: -6.5%.

Estimated limits based on current volatility of 7.3%: low 2.74$, high 3.17$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.11$, 5.19$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.06$, 5.00$]

Financial Metrics affecting the ABSI estimates:

  • Negative: Non-GAAP EPS, $ of -1.02 <= 0.10
  • Negative: Operating profit margin, % of -95.28 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -22.33 <= 2.35
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term ABSI quotes

Long-term ABSI plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $4.78MM $5.75MM $5.72MM
Operating Expenses $80.02MM $112.50MM $121.23MM
Operating Income $-75.24MM $-106.75MM $-115.52MM
Non-Operating Income $-34.62MM $1.39MM $5.05MM
Interest Expense $3.43MM $0.97MM $1.01MM
R&D Expense $44.59MM $58.91MM $48.07MM
Income(Loss) $-109.86MM $-105.36MM $-110.47MM
Taxes $-8.90MM $-0.46MM $0.10MM
Profit(Loss) $-100.96MM $-104.90MM $-110.57MM
Stockholders Equity $366.11MM $274.41MM $176.18MM
Inventory $10.51MM $15.02MM $0.00MM
Assets $426.19MM $321.01MM $217.30MM
Operating Cash Flow $-60.60MM $-81.34MM $-64.64MM
Capital expenditure $38.05MM $16.18MM $0.86MM
Investing Cash Flow $-67.38MM $-126.98MM $81.94MM
Financing Cash Flow $336.19MM $5.24MM $-4.48MM
Earnings Per Share* $-1.09 $-1.15 $-1.20

* EPS are Split Adjusted, recent splits may be reflected with a delay.